Abstract:Ferroptosis, an iron-dependent cell death process, is a potential therapeutic strategy for Lung squamous cell carcinoma (LUSC). Resveratrol (RES) is an anti-tumor polyphenol. However, whether and how RES treats LUSC is not yet known. This study aimed to investigate the effect of RES on LUSC and to explore its potential mechanism. This study used a combination of proteomics, bioinformatics, clinical samples, and cell experiments to study the interaction between HMMR and the ferroptosis signaling pathway and investigate the role of RES in regulating tumor immune microenvironment and anti-tumor by cytotoxic CD8 +T cells in LUSC. Ferroptosis signaling pathway and HMMR were involved in the LUSC tumor immune microenvironment and correlated with worse prognosis of LUSC patients. RES+H520 cells induced a higher level of ferroptosis and MDA, mainly by reducing the expression of GPX4 and SLC7A11, inducing the expression of ACSL4 and TFRC. HMMR, GSH, and SOD contents were lower observed than in H520 cells. When HMMR was expressed, SLC7A11 was also highly expressed in LUSC, and there was an interaction between HMMR expression and SLC7A11. In addition, RES increased the TNF-α, IFN-γ, IL-12, and IL-2 expression and increased the cytotoxic effects of CD8 +T cells expressions in LUSC. Resveratrol regulates SLC7A11-HMMR interaction, activates ferroptosis, enhances the cytotoxic effect of CD8 +T cells, and regulates the tumor immune microenvironment. Based on the pathogenesis of LUSC and the clinical efficacy of RES, this study explored the influence of RES on LUSC, clarified its biological effects, and further provided cell biological basis for the clinical application of RES, which could guide clinical combination and personalized medicine, improve the response rate of immunotherapy and benefit more patients with LUSC.

Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer

Resveratrol: an Overview of Its Anti-Cancer Mechanisms

Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer

Resveratrol and cancer treatment: updates

Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways

Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review

In Vitro and in Vivo Evaluation of the Antitumor Efficiency of Resveratrol Against Lung Cancer

Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases

Recent advance in the study on prevention and treatment for cancer by resveratrol in grape

Resveratrol and its analogues: promising antitumor agents.

Influence of resveratrol on the growth of Lewis lung carcinomas in mice and its underlying mechanism

MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol

Resveratrol for Cancer Therapy: Challenges and Future Perspectives

Anti-melanoma Mechanisms of Resveratrol

In silico studies reveal the anti-osteosarcoma targets and action mechanisms of resveratrol

Resveratrol Enhanced Anticancer Effects Of Cisplatin On Non-Small Cell Lung Cancer Cell Lines By Inducing Mitochondrial Dysfunction And Cell Apoptosis

Study on radiosensitization effect and mechanism of resveratrol on lung A549 cells

Resveratrol Improves the Cytotoxic Effect of CD8 +T Cells in the Tumor Microenvironment by Regulating HMMR/Ferroptosis in Lung Squamous Cell Carcinoma

Molecular mechanism of resveratrol inhibiting proliferation of human lung cancer cells through inducing cell cycle arrest and apoptosis

Regulation of Proliferation and Autophagy and Its Possible Mechanisms of Resveratrol on HepG2 Cells in Hypoxia

Targeting microbiota-host interactions with resveratrol on cancer: Effects and potential mechanisms of action